CDT Equity Inc.
CDT Equity Inc. scores highest on Earnings (100) and lowest on Nitro (1). Its PosiPenta is 49.61 out of 100, around the middle of similar companies.
On the Penta Grid this week, CDT Equity Inc. is Grid #290 of 837 in the Healthcare sector in United States, and Grid #1,922 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| CDT Equity Inc. | 49.61 | 50 | 100 | 1 | 56 | 41 |
| GlucoTrack, Inc. | 11.35 | 0 | 1 | 2 | 10 | 44 |
| Profusa, Inc. | 60.24 | 50 | 100 | 1 | 95 | 56 |
| Curis, Inc. | 42.16 | 96 | 43 | 5 | 41 | 26 |
| Bone Biologics Corporation | 42.16 | 48 | 49 | 14 | 67 | 32 |
| Lakewood-Amedex Biotherapeutics, Inc. | 28.54 | 48 | 10 | 1 | 38 | 46 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 0.00 |
| P/B ratio | 0.00 |
EEarnings
| Trailing EPS | ₹8601301.62 |
| Forward EPS | — |
NNitro
| Price | 22.27 |
| 52-week high | 2219881.70 |
| 52-week low | 17.14 |
| Fall from 52-week high | 100.0% |
TTorque
| Return on equity (ROE) | -69.68% |
| Debt-to-equity | 0.01 |
AAnchor
| Beta (price swings) | 1.56 |
| Market cap | ₹2 Cr |
| Insider holding | 33.93% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is CDT Equity Inc.'s PosiPenta score?
CDT Equity Inc.'s PosiPenta is 49.61 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does CDT Equity Inc. stand on the Penta Grid?
On the Penta Grid this week, CDT Equity Inc. is Grid #290 of 837 in the Healthcare sector in United States, and Grid #1,922 of 4,000 in United States.
Which PosiPenta pillar is strongest for CDT Equity Inc.?
Earnings (growth), with a score of 100 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for CDT Equity Inc.?
Nitro (momentum), with a score of 1 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.